Entries Tagged as ''

How To Prevent Bedsores From Becoming Deadly

It's a good thing we toss and turn in bed. That movement continually redistributes the pressure between our bodies and the mattress. If illness or injury prevents you from moving around, pressure builds up on specific areas of the body. This can cause skin and other tissues to die, creating a bedsore. A few simple steps, however, can help prevent these painful, dangerous, and costly sores, reports the November 2006 issue of the Harvard Health Letter. [click link for full article] (Source: Dermatology News From Medical News Today)

Bedsores can cost $70,000 to treat

It's a good thing for those who toss and turn in bed because movement redistributes the pressure between the body and the mattress, says a U.S. newsletter. (Source: United Press International - Consumer Health)

Stems cells ‘slow nerve disease’

Stem cells show potential for treating motor neurone disease, research suggests. (Source: BBC News | Health | UK Edition)

Health Tip: Prevent Bed Sores

(Source: Dr. Koop News Articles)

Volume 79, number 5: Absence of a Paternally Inherited FOXP2 Gene in Developmental Verbal Dyspraxia

Mutations in FOXP2 cause developmental verbal dyspraxia (DVD), but only a few cases have been described. We characterize 13 patients with DVD—5 with hemizygous paternal deletions spanning the FOXP2 gene, 1 with a translocation interrupting FOXP2, and the remaining 7 with maternal uniparental disomy of chromosome 7 (UPD7), who were also given a diagnosis of Silver-Russell Syndrome (SRS). Of these individuals with DVD, all 12 for whom parental DNA was available showed absence of a paternal copy of FOXP2. Five other individuals with deletions of paternally inherited FOXP2 but with incomplete clinical information or phenotypes too complex to properly assess are also described. Four of the patients with DVD also meet criteria for autism spectrum disorder. Individuals with paternal UPD7 or wit...

Moxifloxacin distribution in the interstitial space of infected decubitus ulcer tissue of patients with spinal cord injury measured by in vivo microdialysis

(Source: Scandinavian Journal of Infectious Diseases)

Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype

Abstract  We have investigated the extent and pattern of immunostaining for ubiquitin protein (UBQ) in 60 patients with frontotemporal lobar degeneration (FTLD) with ubiquitin-positive, tau-negative inclusions (FTLD-U), 37 of whom were ascertained in Manchester UK and 23 in Newcastle-Upon-Tyne, UK. There were three distinct histological patterns according to the form and distribution of the UBQ pathology. Histological type 1 was present in 19 patients (32%) and characterised by the presence of a moderate number, or numerous, UBQ immunoreactive neurites and intraneuronal cytoplasmic inclusions within layer II of the frontal and temporal cerebral cortex, and cytoplasmic inclusions within granule cells of the dentate gyrus; neuronal intranuclear inclusions (NII) of a “cat’s eye” or “lentiform” appearance were present in 17 of these patients. In histological type 2 (16 patients, 27%), UBQ neurites were predominantly, or exclusively, present with few intraneuronal cytoplasmic inclusions within layer II of the cerebral cortex, while in histological type 3 (25 patients, 42%), UBQ intraneuronal cytoplasmic inclusions either within the cortical layer II or in the granule cells of the dentate gyrus, with few or no UBQ neurites, were seen. In neither of these latter two groups were NII present. The influence of histological type on clinical phenotype was highly significant with type 1 histology being associated clinically with cases of frontotemporal dementia (FTD) or progressive non-fluent aphasia (PNFA), type 2 histology with semantic dementia (SD), and type 3 histology with FTD, or FTD and motor neurone disease (MND).
Content TypeJournal Article

JournalActa NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)

 

MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.